Justin Eyquem I TBC
- Speaker: Justin Eyquem, Principal Investigator, Parker Fellow. Microbiology & Immunotherapy, University of California, San Francisco
- Talk title: TBC
- Host: Joaquin Arribas
- Date & time: Friday 27th October, at 17:00 CET
- Online session. Registration
I received my PhD from the University of Paris-Diderot in collaboration with the biotech company Cellectis. During my PhD, I participated to the development of gene editing tools such as Meganuclease or TALEN in primary human cells and notably identified genomic location for safe integration of therapeutic genes. In 2014, I joined Michel Sadelain’s lab at the MSKCC and used CRISPR/Cas9 to engineer CAR T cells. I showed how targeting CAR transgene into specific loci enhance T cell efficacy, advance CAR immuno-biology and facilitate T cell manufacturing. Early 2019, I received the Parker Fellow Award and opened my lab in the department of Microbiology and Immunology at UCSF where I am developing a gene editing platform to enhance CAR T and NK cell functions in hematological and solid tumors.